NEFL and Alzheimer disease: Increases in NFL levels are evident well before the clinical onset of cognitive impairments: a distinct increase in serum NFL in AD-causative mutation carriers was observed 16.2 years earlier than clinical symptoms began, according to the findings of the Dominant Inherited Alzheimer’s Disease Network study19.